The aim of this review was to summarize current knowledge about the scientific findings and potential clinical utility of heart rate variability measures in patients with systemic lupus erythematosus.
Methods
PubMed, Embase and Scopus databases were searched for the terms associated with systemic lupus erythematosus and heart rate variability, including controlled vocabulary, when appropriate. Articles published in English and available in full text were considered. Finally, 11 publications were selected, according to the systematic review protocol and were analyzed.
Results
In general, heart rate variability, measured in the time and frequency domains, was reported to be decreased in patients with systemic lupus erythematosus compared with controls. In some systemic lupus erythematosus studies, heart rate variability was found to correlate with inflammatory markers and albumin levels. A novel heart rate variability measure, heart rate turbulence onset, was shown to be increased, while heart rate turbulence slope was decreased in systemic lupus erythematosus patients. Reports of associations of changes in heart rate variability parameters with increasing systemic lupus erythematosus activity were inconsistent, showing decreasing heart rate variability or no relationship. However, the low/high frequency ratio was, in some studies, reported to increase with increasing disease activity or to be inversely correlated with albumin levels.
Conclusions
Patients with systemic lupus erythematosus have abnormal heart rate variability, which reflects cardiac autonomic dysfunction and may be related to inflammatory cytokines but not necessarily to disease activity. Thus measurement of heart rate variability could be a useful clinical tool for monitoring autonomic dysfunction in systemic lupus erythematosus, and may potentially provide prognostic information.
TsokosGC. Systemic lupus erythematosus. N Engl J Med2011; 365: 2110–21.
2.
OrtonaEPierdominiciMMaselliAVeroniCAloisiFShoenfeldY. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita2016; 52: 205–212.
3.
VincentFBMorandEFSchneiderPMackayF. The BAFF/APRIL system in SLE pathogenesis. Nat Rev Rheumatol2014; 10: 365–373.
4.
KenneyMJGantaCK. Autonomic nervous system and immune system interactions. Compr Physiol2014; 4: 1177–1200.
5.
TincaniARebaioliCBTagliettiMShoenfeldY. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford)2006; 45 (Suppl.) 4: iv8–iv13.
6.
HinojarRFooteLSangleSet al.Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment. Int J Cardiol2016; 222: 717–726.
7.
AlamMMDasPGhoshPet al.Cardiovascular autonomic neuropathy in systemic lupus erythematosus. Indian J Physiol Pharmacol2015; 59: 155–161.
8.
MalpasSC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev2010; 90: 513–557.
9.
SkamraCRamsey-GoldmanR. Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumatol2010; 5: 75–100.
10.
SteinPKPuY. Heart rate variability, sleep and sleep disorders. Sleep Med Rev2012; 16: 47–66.
11.
AcharyaURJosephKPKannathalNLimCMSuriJS. Heart rate variability: a review. Med Biol Engng Comput2006; 44: 1031–1051.
12.
ChemlaDYoungJBadiliniFet al.Comparison of fast Fourier transform and autoregressive spectral analysis for the study of heart rate variability in diabetic patients. Int J Cardiol2005; 104: 307–313.
13.
Soares-MirandaLSattelmairJChavesPet al.Physical activity and heart rate variability in older adults: the Cardiovascular Health Study. Circulation2014; 129: 2100–2110.
14.
SinneckerDDommaschMStegerAet al.Expiration-triggered sinus arrhythmia predicts outcome in survivors of acute myocardial infarction. J Am Coll Cardiol2016; 67: 2213–2220.
15.
DoganYErenGATulubasEOduncuVSahinACiftciS. The effect of sedation during transoesophageal echocardiography on heart rate variability: a comparison of hypnotic sedation with medical sedation. Kardiol Pol2016; 74: 591–597.
16.
MilovanovicBStojanovicLMilicevikNVasicKBjelakovicBKrotinM. Cardiac autonomic dysfunction in patients with systemic lupus, rheumatoid arthritis and sudden death risk. Srp Arh Celok Lek2010; 138: 26–32.
17.
KleigerRESteinPKBiggerJT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol2005; 10: 88–101.
18.
WatanabeMA. Heart rate turbulence: a review. Indian Pacing Electrophysiol J2003; 3: 10–22.
19.
HarrisPRSteinPKFungGLDrewBJ. Prognostic value of heart rate turbulence for risk assessment in patients with unstable angina and non-ST elevation myocardial infarction. Vasc Health Risk Manag2013; 9: 465–473.
20.
FatissonJOswaldVLalondeF. Influence diagram of physiological and environmental factors affecting heart rate variability: an extended literature overview. Heart Int2016; 11: e32–e40.
21.
VaradhanRChavesPHLipsitzLAet al.Frailty and impaired cardiac autonomic control: new insights from principal components aggregation of traditional heart rate variability indices. J Gerontol A Biol Sci Med Sci2009; 64: 682–687.
22.
MatusikPTSteinPK. Overnight Holter electrocardiography: an opportunity for early sleep apnea diagnosis and treatment. J Am Coll Cardiol2017; 70: 809–810.
23.
LaversuchCJSeoHModarresHCollinsDAMcKennaWBourkeBE. Reduction in heart rate variability in patients with systemic lupus erythematosus. J Rheumatol1997; 24: 1540–1544.
24.
ThanouAStavrakisSDyerJWMunroeMEJamesJAMerrillJT. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res Ther2016; 18: 197.
25.
LiberatiAAltmanDGTetzlaffJet al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med2009; 151: W65–W94.
26.
PoliwczakARWaszczykowskaEDziankowska-BartkowiakBKozirogMDworniakK. The use of heart rate turbulence and heart rate variability in the assessment of autonomic regulation and circadian rhythm in patients with systemic lupus erythematosus without apparent heart disease. Lupus2018; 27: 436–444.
27.
YorgunHCanpolatUAytemirKet al.Evaluation of cardiac autonomic functions in patients with systemic lupus erythematosus. Lupus2012; 21: 373–379.
28.
BillmanGE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol2013; 4: 26.
29.
LaganaBSchillaciOTubaniLet al.Lupus carditis: evaluation with technetium-99m MIBI myocardial SPECT and heart rate variability. Angiology1999; 50: 143–148.
30.
BurrRL. Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review. Sleep2007; 30: 913–919.
31.
SteinPKDomitrovichPPHuikuriHVKleigerRECastI. Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol2005; 16: 13–20.
32.
HuikuriHVSteinPK. Heart rate variability in risk stratification of cardiac patients. Prog Cardiovasc Dis2013; 56: 153–159.
33.
HarrisPRSteinPKFungGLDrewBJ. Heart rate variability measured early in patients with evolving acute coronary syndrome and 1-year outcomes of rehospitalization and mortality. Vasc Health Risk Manag2014; 10: 451–464.
34.
AydemirMYazisizVBasariciIet al.Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus2010; 19: 255–261.
AgarwalSKNorbyFLWhitselEAet al.Cardiac autonomic dysfunction and incidence of atrial fibrillation: results from 20 years follow-up. J Am Coll Cardiol2017; 69: 291–299.
37.
HuangSTChenGYWuCHKuoCD. Effect of disease activity and position on autonomic nervous modulation in patients with systemic lupus erythematosus. Clin Rheumatol2008; 27: 295–300.
38.
YipJAghdassiESuJet al.Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. J Rheumatol2010; 37: 1667–1672.
39.
EngelTBen-HorinSBeer-GabelM. Autonomic dysfunction correlates with clinical and inflammatory activity in patients with Crohn's disease. Inflamm Bowel Dis2015; 21: 2320–2326.
40.
YangJLChenGYKuoCD. Comparison of effect of 5 recumbent positions on autonomic nervous modulation in patients with coronary artery disease. Circ J2008; 72: 902–908.
41.
PongratzGStraubRH. The sympathetic nervous response in inflammation. Arthritis Res Ther2014; 16: 504.
42.
WozniackaACygankiewiczIChudzikMSysa-JedrzejowskaAWraniczJK. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters. Lupus2006; 15: 521–525.
43.
BieniasPCiurzynskiMChrzanowskaAet al.Attenuated post-exercise heart rate recovery in patients with systemic lupus erythematosus: the role of disease severity and beta-blocker treatment. Lupus2018; 27: 217–224.
44.
HuangWLLiaoSCKuoTBet al.The effects of antidepressants and quetiapine on heart rate variability. Pharmacopsychiatry2016; 49: 191–198.
45.
NodaYIzunoTTsuchiyaYet al.Acupuncture-induced changes of vagal function in patients with depression: a preliminary sham-controlled study with press needles. Complement Ther Clin Pract2015; 21: 193–200.
46.
BantornwanSWatanapaWBHussarinPet al.Role of meditation in reducing sympathetic hyperactivity and improving quality of life in lupus nephritis patients with chronic kidney disease. J Med Assoc Thai2014; 97(Suppl. 3): S101–S107.
47.
SteinKSMcFarlaneICGoldbergNGinzlerEM. Heart rate variability in patients with systemic lupus erythematosus. Lupus1996; 5: 44–48.
48.
SteinPKDomitrovichPPHuiNRautaharjuPGottdienerJ. Sometimes higher heart rate variability is not better heart rate variability: results of graphical and nonlinear analyses. J Cardiovasc Electrophysiol2005; 16: 954–959.
49.
SteinPKBarzilayJI. Relationship of abnormal heart rate turbulence and elevated CRP to cardiac mortality in low, intermediate, and high-risk older adults. J Cardiovasc Electrophysiol2011; 22: 122–127.
50.
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J1996; 17: 354–3581.
MironovaTMironovVAntufievVSafronovaEMironovMDavydovaE. Heart rate variability analysis at coronary artery disease and angina pectoris. Recent Pat Cardiovasc Drug Discov2009; 4: 45–54.
53.
MathiasCJ. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry2003; 74(Suppl. 3): iii31–iii41.
54.
BalciogluASMuderrisogluH. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes2015; 6: 80–91.
55.
UtsetTOWardABThompsonTLGreenSL. Significance of chronic tachycardia in systemic lupus erythematosus. Arthritis Care Res (Hoboken)2013; 65: 827–831.
56.
MatusikPTTomalaIPiekarzIKarkowskiGKuniewiczMLelakowskiJ. Thyroid goiter: implications for implantation of cardiovascular implantable electronic devices and cannulation of the superior vena cava confluence. Pol Arch Med Wewn2016; 126: 432–434.
57.
MatusikPTMatusikPSKornacewicz-JachZMaleckaBZabekAUndasA. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation. Int J Cardiol2017; 243: 244–250.
58.
SosnowskiMMacfarlanePWTenderaM. Determinants of a reduced heart rate variability in chronic atrial fibrillation. Ann Noninvasive Electrocardiol2011; 16: 321–326.
59.
FreyBHeinzGBinderTet al.Diurnal variation of ventricular response to atrial fibrillation in patients with advanced heart failure. Am Heart J1995; 129: 58–65.
60.
BialasARPresumeyJDasAet al.Microglia-dependent synapse loss in type I interferon-mediated lupus. Nature2017; 546: 539–543.
AronsonDBurgerAJ. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int J Cardiol2001; 79: 31–39.
63.
LampertRIckovicsJRViscoliCJHorwitzRILeeFA. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Am J Cardiol2003; 91: 137–142.
64.
Menezes AdaS JrMoreiraHGDaherMT. Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors. Arq Bras Cardiol2004; 83: 169–172. 5–8.
65.
LaganaBTubaniLMaffeoNet al.Heart rate variability and cardiac autonomic function in systemic lupus erythematosus. Lupus1996; 5: 49–55.
66.
NovikovaDSPopkovaTVPanafidinaTAet al.[Clinical significance of heart rate variability in patients with systemic lupus erythematosus]. Ter Arkh2008; 80: 68–72.
67.
WraniczJKCygankiewiczIZielinskaMWozniackaASysa-JedrzejowskaA. Non-invasive cardiac evaluation in patients with systemic lupus erythematosus. J Med2001; 32: 195–206.
68.
WraniczJKWozniackaAZielinskaMCygankiewiczISysa-JedrzejowskaA. Holter monitoring in patients with systemic lupus erythematosus: evaluation of dysauthonomia. J Cardiovasc Diagn P1999; 16: 67–71.
